Ethambutol 2HCl

Catalog No.S4004 Synonyms: CL40881

For research use only.

Ethambutol 2HCl (CL40881) is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases.

Ethambutol 2HCl Chemical Structure

CAS No. 1070-11-7

Selleck's Ethambutol 2HCl has been cited by 1 Publication

Purity & Quality Control

Choose Selective Bacterial Inhibitors

Biological Activity

Description Ethambutol 2HCl (CL40881) is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases.
In vitro

Ethambutol directly affects two polymers, arabinogalactan (AG) and lipoarabinomannan (LAM) in Mycobacterium smegmatis. In M. smegmatis, Ethambutol inhibits synthesis of arabinan completely and inhibits AG synthesis most likely as a consequence of this; more than 50% of the cell arabinan is released from the bacteria following Ethambutol treatment, whereas no galactan is released. Ethambutol main targets against embB gene product in M. avium. Ethambutol induces 60% changes in the embB gene in M. tuberculosis resistant mutants. [1] Ethambutol is effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis. Nearly all strains of M. tuberculosis and M. kansasii as well as a number of strains of the M. aviumcomplex (MAC) are sensitive to Ethambutol. [1] Ethambutol is potency against M. tuberculosis (H37Rv) with MIC of 0.5 μg/mL in vitro. [2] Ethambutol is efficient on treatment of mycobacterial-infected macrophages. When M. tuberculosis infected macrophages are treated with 6 μg/mL Ethambutol, the log CFUs following treatment for 3 days is 4.17, while value in control group is 4.8. The MICs for M. avium (MTCC 1723) and M. smegmatis (MTCC 6) are 15 μg/mL and 0.18 μg/mL, respectively. [3]

In vivo Ethambutol is efficient in animal model. 100 mg/kg Ethambutol given orally 15 days post i.v. infection 1 ×/week for 5 weeks, induces a lower log CFU compared with untreatment (4.59 vs 5.07). [3]

Protocol (from reference)

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 277.23
Formula

C10H24N2O2.2HCl

CAS No. 1070-11-7
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles CCC(CO)NCCNC(CC)CO.Cl.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04972903 Not yet recruiting -- Tuberculosis|Pulmonary Institut National de la Santé Et de la Recherche Médicale France|National Agency for Research on AIDS and Viral Hepatitis (ANRS) August 2021 --
NCT02114684 Completed Drug: moxifloxacin Recurrent Tuberculosis Centre for the AIDS Programme of Research in South Africa November 2013 Phase 1|Phase 2
NCT02496572 Unknown status Drug: Short course MDR-TB treatment regimen Multidrug Resistant Tuberculosis Medecins Sans Frontieres Netherlands|Ministry of Health Republic of Uzbekistan|Imperial College London September 2013 --

(data from https://clinicaltrials.gov, updated on 2022-08-01)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ethambutol 2HCl | Ethambutol 2HCl ic50 | Ethambutol 2HCl price | Ethambutol 2HCl cost | Ethambutol 2HCl solubility dmso | Ethambutol 2HCl purchase | Ethambutol 2HCl manufacturer | Ethambutol 2HCl research buy | Ethambutol 2HCl order | Ethambutol 2HCl mouse | Ethambutol 2HCl chemical structure | Ethambutol 2HCl mw | Ethambutol 2HCl molecular weight | Ethambutol 2HCl datasheet | Ethambutol 2HCl supplier | Ethambutol 2HCl in vitro | Ethambutol 2HCl cell line | Ethambutol 2HCl concentration | Ethambutol 2HCl nmr